跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLN-OLMESARTAN HCTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLN-OLMESARTAN HCTZ
Authorized
STANDARD
GLN-OLMESARTAN HCTZ
glenmark pharmaceuticals canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
784e2e46a379aa95
Company
glenmark pharmaceuticals canada inc.
Type
Standard
Approval Details
Approval Id
784e2e46a379aa95
Drug Approval Canada Name
GLN-OLMESARTAN HCTZ
Product Name
GLN-OLMESARTAN HCTZ
Status
Marketed
Status Date
2020-02-28
Original Market Date
2020-02-28
Din
02475723
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.20
Atc Original
C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS
Atc Name
c 09 da 08
Aig Number
0252502003
Company Name
glenmark pharmaceuticals canada inc.
Company Address
1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2
Active Ingredients
HYDROCHLOROTHIAZIDE
25 MG
OLMESARTAN MEDOXOMIL
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
784e2e46a379aa95
Type
Standard
Back to Health Canada Approvals